Document is current
Any future updates will be listed below
-
Authors
DeMartino, Anthony W. https://orcid.org/0000-0001-5303-5758
Poudel, Laxman
Dent, Matthew R. https://orcid.org/0000-0002-7704-4867
Chen, Xiukai
Xu, Qinzi
Gladwin, Brendan S.
Tejero, Jesús https://orcid.org/0000-0003-3245-9978
Basu, Swati
Alipour, Elmira
Jiang, Yiyang
Rose, Jason J.
Gladwin, Mark T. https://orcid.org/0000-0001-7267-9006
Kim-Shapiro, Daniel B. https://orcid.org/0000-0003-4383-3101
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL125886, R01 HL098032, R01 HL125886, K08 HL136857, R01 HL098032)
U.S. Department of Defense (W81XWH2210198, W81XWH2210198)
- License Information
-
More Information
Article History
Received: 21 December 2022
Accepted: 27 July 2023
First Online: 14 September 2023
Competing interests
: A.W.D., J.J.R., M.T.G., J.T., M.R.D., D.B.K.-S. and L.P. have a provisional patent filed at the University of Pittsburgh (application no. 63/420,030), related to the creation and use of NO-ferroheme. Though not related directly to NO-ferroheme, A.W.D., J.T., J.J.R., M.T.G., M.R.D. and Q.X. are co-inventors on patents and patent applications directed at the use of heme proteins as therapeutic agents. M.T.G., D.B.K.-S. and J.J.R. are co-inventors on patent and/or patent applications related to sodium nitrite as a therapeutic. Some of these patents are licensed to Globin Solutions, Inc. J.J.R., M.T.G. and J.T. are shareholders of Globin Solutions. J.J.R. and J.T. are officers and directors of Globin Solutions. A.W.D. is a consultant of Globin Solutions. M.T.G. is a consultant, director and scientific advisor to Globin Solutions. The other authors declare no competing interests.
